Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
We present an implementation of a method we previously reported allowing the newer antiepileptic drugs (AEDs) rufinamide (RFN) and zonisamide (ZNS) to be simultaneously determined with lamotrigine (LTG), oxcarbazepine's (OXC) main active metabolite monohydroxycarbamazepine (MHD) and felbamate (FBM) in plasma of patients with epilepsy using high performance liquid chromatography (HPLC) with UV detection. Plasma samples (250 microL) were deproteinized by 1 mL acetonitrile spiked with citalopram as internal standard (I.S.). HPLC analysis was carried out on a Synergi 4 microm Hydro-RP, 250 mm x 4.6 mm I.D. column. The mobile phase was a mixture of potassium dihydrogen phosphate buffer (50 mM, pH 4.5), acetonitrile and methanol (65:26.2:8.8, v/v/v) at an isocratic flow rate of 0.8 mL/min. The UV detector was set at 210 nm. The chromatographic run lasted 19 min. Commonly coprescribed AEDs did not interfere with the assay. Calibration curves were linear for both AEDs over a range of 2-40 microg/mL for RFN and 2-80 microg/mL for ZNS. The limit of quantitation was 2 microg/mL for both analytes and the absolute recovery ranged from 97% to 103% for RFN, ZNS and the I.S. Intra- and interassay precision and accuracy were lower than 10% at all tested concentrations. The present study describes the first simple and validated method for RFN determination in plasma of patients with epilepsy. By grouping different new AEDs in the same assay the method can be advantageous for therapeutic drug monitoring (TDM).
Contin
Manuela
M
Laboratory of Clinical Neuropharmacology, Neurology Clinic, Department of Neurological Sciences, University of Bologna, Via Foscolo 7, 40123 Bologna, Italy. manuela.contin@unibo.it
Mohamed
Susan
S
Candela
Carmina
C
Albani
Fiorenzo
F
Riva
Roberto
R
Baruzzi
Agostino
A
D000927:Anticonvulsants / Q000097:blood* / Q000737:chemistry; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000097:blood / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation* / Q000379:methods*; D004827:Epilepsy / Q000097:blood*; D000078328:Felbamate; D006801:Humans; D007555:Isoxazoles / Q000097:blood / Q000737:chemistry; D000077213:Lamotrigine; D000078330:Oxcarbazepine; D048448:Phenylcarbamates / Q000097:blood / Q000737:chemistry; D011409:Propylene Glycols / Q000097:blood / Q000737:chemistry; D014227:Triazines / Q000097:blood / Q000737:chemistry; D014230:Triazoles / Q000097:blood / Q000737:chemistry; D014466:Ultraviolet Rays; D000078305:Zonisamide
D000927:Anticonvulsants; D007555:Isoxazoles; D048448:Phenylcarbamates; D011409:Propylene Glycols; D014227:Triazines; D014230:Triazoles; D002220:Carbamazepine; D000078305:Zonisamide; D000077213:Lamotrigine; D000078330:Oxcarbazepine; C079703:rufinamide; D000078328:Felbamate